3 min read Business Sensei Biotherapeutics Completes Faeth Acquisition, Secures $200M Financing Editorial 25 February, 2026 Sensei Biotherapeutics (NASDAQ: SNSE) has finalized its acquisition of Faeth Therapeutics, a clinical-stage company,...Read More
